Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) Immunisation and vaccination (21)
  • (-) Biobased economy (4)
  • (-) Chroom-6 (1)
  • International (264)
  • COVID-19 vaccination (159)
  • COVID-19 (149)
  • National Immunisation Programme (22)
  • Antimicrobial resistance (19)
  • Tobacco (19)
  • Air (17)
  • Circular economy (17)
  • COVID-19 (14)
  • HPV vaccination (14)
  • Zoonotic diseases (14)
  • Heat (13)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (13)
  • Flu and flu vaccine (12)
  • Healthy living environment (11)
  • Nanotechnology (11)
  • One Health (11)
  • Tick bites (11)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (11)
  • Ebola (10)
  • Food safety (10)
  • Health research for COVID-19 (10)
  • Medical devices (10)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (10)
  • Plastics (9)
  • Nitrogen (8)
  • Sexually transmitted infections (STIs) (8)
  • Soil and water (8)
  • Tuberculosis (8)
  • Measles (7)
  • Mpox (7)
  • PFAS (7)
  • Population screening programmes (7)
  • Sustainability (7)
  • Sustainable Development Goals (7)
  • WHO Collaborating Centre on Chemical Food Safety (7)
  • Food and Nutrition (6)
  • Public Health Foresight (6)
  • Salmonella (6)
  • Tick-borne encephalitis (6)
  • MERS-coronavirus (5)
  • Occupational Safety (5)
  • WHO Collaborating Centre for Nutrition (5)
  • Accidents and disasters (4)
  • Bisphenol A (BPA) (4)
  • Dutch National Food Consumption Survey (4)
  • Hydrofluorocarbons (4)
  • Rubber granulate (4)
  • Alternatives to animal testing (3)
  • Chromium (VI) and CARC (3)
  • Climate change and Health (3)
  • ConsExpo (3)
  • Heel prick (3)
  • International projects (3)
  • Legionnaires' disease (Legionellosis) (3)
  • Meningococcal ACWY (3)
  • Mosquitos (3)
  • Perinatal screening (3)
  • Pharmaceuticals in the environment (3)
  • Physical Activity (3)
  • RSV (3)
  • UV index (3)
  • West Nile fever (3)
  • Assistance RIVM Sint Maarten landfill (2)
  • CAESAR (2)
  • Cervical cancer screening programme (2)
  • Consumer exposure to chemical substances (2)
  • Dutch Food Composition Database (NEVO) (2)
  • Population screening programmes in the Caribbean Netherlands (2)
  • Beeldschermgebruik (1)
  • Breast Cancer Screening Programme (1)
  • Chikungunya (1)
  • Chikungunya (1)
  • Dengue (1)
  • E-health (digitale zorg) (1)
  • GenX (1)
  • Health promotion (1)
  • HPV - Humaan Papillomavirus (1)
  • Leefstijlmonitor (1)
  • Lifestyle interventions (1)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (1)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (1)
  • PFAS (1)
  • PFOA (1)
  • Pneumococci (1)
  • Polio (1)
  • Radiation exposure in the Netherlands (1)
  • Rotavirus (1)
  • Screening for Down’s, Edwards’, Patau’s syndromes and ultrasound (1)
  • Sewage research (1)
  • Sustainable procurement (1)
  • Synthetic biology (1)
  • Tata Steel (Corus) (1)
  • Veilige leefomgeving (1)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (1)
  • WHO Collaborating Centre on Life Course and Health (1)
  • Zika Virus (1)

Publication date

  • February 2023 (1)
  • July 2022 (2)
  • January 2022 (1)
  • November 2021 (1)
  • September 2021 (1)
  • November 2020 (1)
  • June 2020 (1)
  • January 2020 (1)
  • December 2019 (2)
  • September 2019 (1)
  • May 2019 (1)
  • April 2019 (1)
  • March 2019 (1)
  • February 2019 (1)
  • December 2018 (1)
  • September 2018 (2)
  • June 2018 (1)
  • December 2017 (1)
  • May 2017 (1)
  • June 2015 (1)
  • January 2015 (2)
  • November 2014 (1)

Provisional figures on participation in the National Immunisation Programme

According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).

02-02-2023 | 11:00
baby en peuter

Side effect reports National Immunisation Programme 2021

Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
25-07-2022 | 17:10
Meisje vier jaar

Participation in National Immunisation Programme shows slight decrease

Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.

04-07-2022 | 12:30
Rijksvaccinatie voorkant rapport

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
31-01-2022 | 14:58
Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

The National Immunisation Programme: the number of disease notifications decreased substantially in 2020

In 2020, fewer people fell ill from a disease against which vaccination is included in the National Immunisation Programme than in 2019. This is most likely due to coronavirus measures, such as social distancing, handwashing, and travel restrictions.
24-11-2021 | 22:45

Vaccination coverage increases for second consecutive year, by 10% for HPV

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.
30-09-2021 | 11:25
Het aantal jonge vrouwen dat zich laat vaccineren tegen HPV is toegenomen met 10%

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
26-11-2020 | 10:15

Corona crisis has limited impact on infant participation in National Immunisation Programme

Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
04-06-2020 | 12:38

More children vaccinated against mumps, measles, rubella and HPV

The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.

30-01-2020 | 15:44

A pregnant woman can protect her baby against whooping cough with 22-week vaccination

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.

12-12-2019 | 11:00

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • › Next ›
  • » Last »

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS reed
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram